PLASMA PCSK9 AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES

被引：0
|
作者：
El Khoury, Petra [1 ,2 ]
Roussel, Ronan [3 ,4 ,5 ]
Fumeron, Frederic [4 ,5 ]
Velho, Gilberto [5 ]
Jacob, Marie-Paule [1 ,4 ]
Steg, Gabriel [1 ,4 ,6 ,7 ]
Potier, L. [3 ,4 ,5 ]
Ghaleb, Youmna [1 ,2 ,4 ]
Elbitar, Sandy [1 ,2 ,4 ]
Abifadel, Marianne [1 ,2 ]
Boileau, Catherine [1 ,4 ,8 ]
Marre, Michel [3 ,4 ,5 ]
Varret, Mathilde [1 ,4 ]
Hansel, Boris [3 ,4 ,5 ]
机构：
[1] INSERM, U1148, Paris, France
[2] St Joseph Univ, Beruth, Lebanon
[3] CHU Bichat, Aphp, Dept Nutr, Paris, France
[4] Denis Diderot Univ Paris 7, Paris, France
[5] INSERM, U1138, Paris, France
[6] CHU Bichat, Aphp, Dept Cardiol, Paris, France
[7] Imperial Coll, NHLI, Royal Brompton Hosp, London, England
[8] CHU Bichat, Aphp, Dept Genet, Paris, France
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG142
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 50 条
  • [21] Analysis of the Association between PCSK9 Levels and Plasma Lipid Levels in Cameroonians with Type 2 Diabetes
    Camille, B. M.
    Mbacham, Wilfred F.
    Sobngwi, Eugene
    Mbanya, Jean Claude
    DIABETES, 2018, 67
  • [22] Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders
    Ibarretxe, Daiana
    Girona, Josefa
    Plana, Nuria
    Cabre, Anna
    Ferre, Raimon
    Amigo, Nuria
    Guaita, Sandra
    Mallol, Roger
    Heras, Mercedes
    Masana, Luis
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (02): : 71 - 78
  • [23] PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
    Rogacev, Kyrill S.
    Heine, Gunnar H.
    Silbernagel, Guenther
    Kleber, Marcus E.
    Seiler, Sarah
    Emrich, Insa
    Lennartz, Simone
    Werner, Christian
    Zawada, Adam M.
    Fliser, Danilo
    Boehm, Michael
    Maerz, Winfried
    Scharnagl, Hubert
    Laufs, Ulrich
    PLOS ONE, 2016, 11 (01):
  • [24] PCSK9 inhibitors and cardiovascular outcomes
    Steffens, Daniel
    Bramlage, Peter
    Scheeff, Celine
    Kasner, Mario
    Hassanein, Adel
    Friebel, Julian
    Rauch-Kroehnert, Ursula
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (01) : 35 - 47
  • [25] Effects of a 12-week Exercise Intervention on Plasma PCSK9 Levels in Patients with Type 2 Diabetes
    Zhang, Wenduo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : S65 - S65
  • [26] Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes
    Yang, Sheng-Hua
    Li, Sha
    Zhang, Yan
    Xu, Rui-Xia
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Cui, Chuan-Jue
    Sun, Jing
    Li, Jian-Jun
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (02) : 193 - 199
  • [27] Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation
    Pastori, D.
    Carnevale, R.
    Nocella, C.
    Bartimoccia, S.
    Vicario, T.
    Menichelli, D.
    Violi, F.
    Pignatelli, P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 382 - 382
  • [28] Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
    Hwang, Hyeon Seok
    Kim, Jin Sug
    Kim, Yang Gyun
    Lee, So-Young
    Ahn, Shin Young
    Lee, Hong Joo
    Lee, Dong-Young
    Lee, Sang Ho
    Moon, Ju Young
    Jeong, Kyung Hwan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [29] PCSK9 inhibitors and diabetes risk
    Mueller-Wieland, Dirk
    DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (02) : 140 - 141
  • [30] PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation
    Carnevale, R.
    Cammisotto, V.
    Nocella, C.
    Bartimoccia, S.
    Pastori, D.
    Violi, F.
    Pignatelli, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3338 - 3338
12345